V-Set Domain-Containing T-Cell Activation Inhibitor 1 (VTCN1) Antibody

Product Graph
364€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
V-Set Domain-Containing T-Cell Activation Inhibitor 1 (VTCN1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx239461
tested applications
ELISA, WB, IHC

Description

VTCN1 Antibody is a Rabbit Polyclonal against VTCN1.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
V-Set Domain-Containing T-Cell Activation Inhibitor 1 (VTCN1)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
WB: 1/200 - 1/2000, IHC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purity
≥ 95% (SDS-PAGE)
Purification
Purified by immunogen affinity chromatography.
Size 1
100 µg
Form
Liquid
Tested Applications
ELISA, WB, IHC
Buffer
PBS, pH 7.3, with 0.02% sodium azide and 50% glycerol.
Availability
Shipped within 5-12 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q7Z7D3
Background
Antibody anti-VTCN1
Status
RUO
Note
Concentration: 2 mg/ml - Validity: 12 months.

Descripción

Related Products

EH1214

Human VTCN1 (V-set domain-containing T-cell activation inhibitor 1) ELISA Kit

Ver Producto
FNab09461

VTCN1 antibody

Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells(Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation.

Ver Producto
P1973

Recombinant Human VTCN1

Ver Producto